Tue, June 13, 2017
Mon, June 12, 2017
Fri, June 9, 2017
Thu, June 8, 2017
Wed, June 7, 2017
Tue, June 6, 2017
Mon, June 5, 2017

Matthew Luchini Upgraded (BLUE) to Buy and Increased Target to $108 on, Jun 6th, 2017

Matthew Luchini of BMO Capital, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Increased Target from $61 to $108 on, Jun 6th, 2017.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jason McCarthy of "Maxim Group" Downgraded from Strong Buy to Hold on, Tuesday, February 28th, 2017